Tradename: VOWST
Proper Name: fecal microbiota spores, live-brpk
Indication: To prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI).
Approval Date: 04/26/2023
Manufacturer: Seres Therapeutics, Inc.
More: https://www.fda.gov/vaccines-blood-biologics/vowst